Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Search results for:
codeine-guaifenesin
codeine-guaifenesin
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Cheratussin AC
SYRUP, ORAL
10 mg-100 mg/5 mL
Codeine Phosphate-GuaiFENesin
SYRUP, ORAL
10 mg-100 mg/5 mL
VIEW MORE
Opioid Agonists
,
Antitussives
,
Expectorants
CLASS
280808
,
480800
,
481600
Additional Information:
Drug Name
Common Side Effects
codeine-guaifenesin
sleepiness, dizziness
GI: nausea, vomiting, constipation
increased effort to breath
Last updated:
Aug. 22, 2022
Black Box Warning:
Codeine in children: death due to ultra-rapid metabolism
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
codeine-guaifenesin
codeine-guaifenesin